nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP1A2—Progesterone—uterine cancer	0.0775	0.181	CbGbCtD
Fluphenazine—ABCB1—Progesterone—uterine cancer	0.0678	0.158	CbGbCtD
Fluphenazine—CYP2D6—Progesterone—uterine cancer	0.0638	0.149	CbGbCtD
Fluphenazine—CYP2E1—Etoposide—uterine cancer	0.06	0.14	CbGbCtD
Fluphenazine—ABCB1—Dactinomycin—uterine cancer	0.0537	0.126	CbGbCtD
Fluphenazine—CYP1A2—Etoposide—uterine cancer	0.0347	0.081	CbGbCtD
Fluphenazine—ABCB1—Etoposide—uterine cancer	0.0303	0.0709	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—uterine cancer	0.0207	0.0483	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—uterine cancer	0.0195	0.0455	CbGbCtD
Fluphenazine—CALM2—semen—uterine cancer	0.0105	0.0646	CbGeAlD
Fluphenazine—CALM1—semen—uterine cancer	0.0105	0.0643	CbGeAlD
Fluphenazine—CALM2—oviduct—uterine cancer	0.00771	0.0474	CbGeAlD
Fluphenazine—Throat tightness—Progesterone—uterine cancer	0.00658	0.0274	CcSEcCtD
Fluphenazine—Parkinsonism—Medroxyprogesterone Acetate—uterine cancer	0.00643	0.0268	CcSEcCtD
Fluphenazine—Menstruation irregular—Progesterone—uterine cancer	0.00583	0.0243	CcSEcCtD
Fluphenazine—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.00528	0.022	CcSEcCtD
Fluphenazine—CALM2—artery—uterine cancer	0.0051	0.0314	CbGeAlD
Fluphenazine—CALM1—artery—uterine cancer	0.00508	0.0312	CbGeAlD
Fluphenazine—Pigmentation disorder—Etoposide—uterine cancer	0.00494	0.0206	CcSEcCtD
Fluphenazine—Libido increased—Medroxyprogesterone Acetate—uterine cancer	0.00481	0.02	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Progesterone—uterine cancer	0.00473	0.0197	CcSEcCtD
Fluphenazine—Laryngeal oedema—Medroxyprogesterone Acetate—uterine cancer	0.00455	0.019	CcSEcCtD
Fluphenazine—CALM2—exocrine gland—uterine cancer	0.00445	0.0274	CbGeAlD
Fluphenazine—CALM1—exocrine gland—uterine cancer	0.00443	0.0272	CbGeAlD
Fluphenazine—Tenderness—Progesterone—uterine cancer	0.0037	0.0154	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Progesterone—uterine cancer	0.00367	0.0153	CcSEcCtD
Fluphenazine—Blood disorder—Medroxyprogesterone Acetate—uterine cancer	0.0035	0.0146	CcSEcCtD
Fluphenazine—Throat tightness—Etoposide—uterine cancer	0.00336	0.014	CcSEcCtD
Fluphenazine—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.00335	0.0139	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.00333	0.0138	CcSEcCtD
Fluphenazine—Faecaloma—Epirubicin—uterine cancer	0.00324	0.0135	CcSEcCtD
Fluphenazine—Faecalith—Epirubicin—uterine cancer	0.00324	0.0135	CcSEcCtD
Fluphenazine—Hepatocellular injury—Progesterone—uterine cancer	0.00323	0.0134	CcSEcCtD
Fluphenazine—CALM3—myometrium—uterine cancer	0.00314	0.0193	CbGeAlD
Fluphenazine—Leukocytosis—Medroxyprogesterone Acetate—uterine cancer	0.00311	0.0129	CcSEcCtD
Fluphenazine—HTR2A—artery—uterine cancer	0.00309	0.019	CbGeAlD
Fluphenazine—Faecaloma—Doxorubicin—uterine cancer	0.003	0.0125	CcSEcCtD
Fluphenazine—Faecalith—Doxorubicin—uterine cancer	0.003	0.0125	CcSEcCtD
Fluphenazine—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.00292	0.0122	CcSEcCtD
Fluphenazine—Pigmentation disorder—Epirubicin—uterine cancer	0.00277	0.0115	CcSEcCtD
Fluphenazine—Nasal congestion—Progesterone—uterine cancer	0.00257	0.0107	CcSEcCtD
Fluphenazine—Pigmentation disorder—Doxorubicin—uterine cancer	0.00256	0.0107	CcSEcCtD
Fluphenazine—CALM2—myometrium—uterine cancer	0.00247	0.0152	CbGeAlD
Fluphenazine—CALM1—myometrium—uterine cancer	0.00245	0.0151	CbGeAlD
Fluphenazine—CALM3—uterine cervix—uterine cancer	0.00244	0.015	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Progesterone—uterine cancer	0.00242	0.0101	CcSEcCtD
Fluphenazine—CALM3—smooth muscle tissue—uterine cancer	0.00237	0.0146	CbGeAlD
Fluphenazine—CALM3—decidua—uterine cancer	0.00233	0.0143	CbGeAlD
Fluphenazine—Disturbance in sexual arousal—Progesterone—uterine cancer	0.00232	0.00967	CcSEcCtD
Fluphenazine—CALM3—endometrium—uterine cancer	0.00221	0.0136	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00913	CcSEcCtD
Fluphenazine—CALM3—mammalian vulva—uterine cancer	0.00214	0.0131	CbGeAlD
Fluphenazine—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00876	CcSEcCtD
Fluphenazine—CALM3—uterus—uterine cancer	0.00204	0.0125	CbGeAlD
Fluphenazine—Dysphagia—Progesterone—uterine cancer	0.00202	0.00842	CcSEcCtD
Fluphenazine—Asthma—Progesterone—uterine cancer	0.00202	0.00842	CcSEcCtD
Fluphenazine—CALM2—epithelium—uterine cancer	0.00194	0.0119	CbGeAlD
Fluphenazine—CALM1—epithelium—uterine cancer	0.00193	0.0118	CbGeAlD
Fluphenazine—CALM2—uterine cervix—uterine cancer	0.00192	0.0118	CbGeAlD
Fluphenazine—CALM1—uterine cervix—uterine cancer	0.00191	0.0117	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Progesterone—uterine cancer	0.00188	0.00783	CcSEcCtD
Fluphenazine—CALM2—smooth muscle tissue—uterine cancer	0.00186	0.0115	CbGeAlD
Fluphenazine—CALM1—smooth muscle tissue—uterine cancer	0.00186	0.0114	CbGeAlD
Fluphenazine—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00763	CcSEcCtD
Fluphenazine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00763	CcSEcCtD
Fluphenazine—CALM2—decidua—uterine cancer	0.00183	0.0112	CbGeAlD
Fluphenazine—HTR1A—renal system—uterine cancer	0.00183	0.0112	CbGeAlD
Fluphenazine—CALM1—decidua—uterine cancer	0.00182	0.0112	CbGeAlD
Fluphenazine—Pneumonia—Progesterone—uterine cancer	0.00182	0.00756	CcSEcCtD
Fluphenazine—Drowsiness—Progesterone—uterine cancer	0.0018	0.00751	CcSEcCtD
Fluphenazine—CALM2—renal system—uterine cancer	0.00179	0.011	CbGeAlD
Fluphenazine—HRH1—myometrium—uterine cancer	0.00179	0.011	CbGeAlD
Fluphenazine—CALM1—renal system—uterine cancer	0.00179	0.011	CbGeAlD
Fluphenazine—ADRA2A—myometrium—uterine cancer	0.00176	0.0108	CbGeAlD
Fluphenazine—HTR2C—female reproductive system—uterine cancer	0.00174	0.0107	CbGeAlD
Fluphenazine—CALM2—endometrium—uterine cancer	0.00174	0.0107	CbGeAlD
Fluphenazine—Body temperature increased—Carboplatin—uterine cancer	0.00173	0.00721	CcSEcCtD
Fluphenazine—CALM1—endometrium—uterine cancer	0.00173	0.0106	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00709	CcSEcCtD
Fluphenazine—Lethargy—Dactinomycin—uterine cancer	0.00169	0.00703	CcSEcCtD
Fluphenazine—CALM2—mammalian vulva—uterine cancer	0.00168	0.0103	CbGeAlD
Fluphenazine—CALM1—mammalian vulva—uterine cancer	0.00167	0.0103	CbGeAlD
Fluphenazine—CALM3—female gonad—uterine cancer	0.00167	0.0102	CbGeAlD
Fluphenazine—CALM3—vagina—uterine cancer	0.00166	0.0102	CbGeAlD
Fluphenazine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00681	CcSEcCtD
Fluphenazine—CALM2—uterus—uterine cancer	0.0016	0.00983	CbGeAlD
Fluphenazine—Oedema peripheral—Progesterone—uterine cancer	0.0016	0.00664	CcSEcCtD
Fluphenazine—CALM1—uterus—uterine cancer	0.00159	0.00979	CbGeAlD
Fluphenazine—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00602	CcSEcCtD
Fluphenazine—CALM2—female reproductive system—uterine cancer	0.00144	0.00884	CbGeAlD
Fluphenazine—CALM1—female reproductive system—uterine cancer	0.00143	0.0088	CbGeAlD
Fluphenazine—Dysphagia—Dactinomycin—uterine cancer	0.00143	0.00595	CcSEcCtD
Fluphenazine—Erythema—Progesterone—uterine cancer	0.00141	0.00587	CcSEcCtD
Fluphenazine—HRH1—epithelium—uterine cancer	0.0014	0.00864	CbGeAlD
Fluphenazine—HRH1—uterine cervix—uterine cancer	0.00139	0.00856	CbGeAlD
Fluphenazine—CYP1A2—renal system—uterine cancer	0.00139	0.00856	CbGeAlD
Fluphenazine—ADRA2A—uterine cervix—uterine cancer	0.00137	0.00841	CbGeAlD
Fluphenazine—Pancytopenia—Dactinomycin—uterine cancer	0.00136	0.00565	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Epirubicin—uterine cancer	0.00136	0.00565	CcSEcCtD
Fluphenazine—Muscle spasms—Progesterone—uterine cancer	0.00136	0.00564	CcSEcCtD
Fluphenazine—HRH1—smooth muscle tissue—uterine cancer	0.00135	0.00832	CbGeAlD
Fluphenazine—Vision blurred—Progesterone—uterine cancer	0.00133	0.00553	CcSEcCtD
Fluphenazine—HRH1—decidua—uterine cancer	0.00133	0.00816	CbGeAlD
Fluphenazine—CALM2—female gonad—uterine cancer	0.00131	0.00804	CbGeAlD
Fluphenazine—ADRA2A—decidua—uterine cancer	0.0013	0.00802	CbGeAlD
Fluphenazine—CALM1—female gonad—uterine cancer	0.0013	0.00801	CbGeAlD
Fluphenazine—CALM2—vagina—uterine cancer	0.0013	0.00799	CbGeAlD
Fluphenazine—CALM1—vagina—uterine cancer	0.00129	0.00796	CbGeAlD
Fluphenazine—Angioedema—Progesterone—uterine cancer	0.00129	0.00536	CcSEcCtD
Fluphenazine—Pneumonia—Dactinomycin—uterine cancer	0.00128	0.00534	CcSEcCtD
Fluphenazine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00532	CcSEcCtD
Fluphenazine—HRH1—endometrium—uterine cancer	0.00126	0.00775	CbGeAlD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—uterine cancer	0.00126	0.00523	CcSEcCtD
Fluphenazine—CYP2E1—renal system—uterine cancer	0.00125	0.0077	CbGeAlD
Fluphenazine—Dermatitis atopic—Epirubicin—uterine cancer	0.00125	0.0052	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Etoposide—uterine cancer	0.00124	0.00515	CcSEcCtD
Fluphenazine—ADRA2A—endometrium—uterine cancer	0.00124	0.00761	CbGeAlD
Fluphenazine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00511	CcSEcCtD
Fluphenazine—HRH1—mammalian vulva—uterine cancer	0.00122	0.00749	CbGeAlD
Fluphenazine—Hypertension—Progesterone—uterine cancer	0.00122	0.00507	CcSEcCtD
Fluphenazine—ADRA2A—mammalian vulva—uterine cancer	0.0012	0.00736	CbGeAlD
Fluphenazine—Agranulocytosis—Dactinomycin—uterine cancer	0.00119	0.00495	CcSEcCtD
Fluphenazine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00489	CcSEcCtD
Fluphenazine—Dry mouth—Progesterone—uterine cancer	0.00117	0.00489	CcSEcCtD
Fluphenazine—HTR2A—epithelium—uterine cancer	0.00117	0.00721	CbGeAlD
Fluphenazine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00486	CcSEcCtD
Fluphenazine—Dermatitis atopic—Doxorubicin—uterine cancer	0.00116	0.00481	CcSEcCtD
Fluphenazine—Anaphylactic shock—Progesterone—uterine cancer	0.00115	0.00479	CcSEcCtD
Fluphenazine—ADRA2A—uterus—uterine cancer	0.00114	0.00701	CbGeAlD
Fluphenazine—Cardiac arrest—Etoposide—uterine cancer	0.00114	0.00474	CcSEcCtD
Fluphenazine—HTR2A—smooth muscle tissue—uterine cancer	0.00113	0.00695	CbGeAlD
Fluphenazine—Tachycardia—Progesterone—uterine cancer	0.00112	0.00468	CcSEcCtD
Fluphenazine—Skin disorder—Progesterone—uterine cancer	0.00112	0.00465	CcSEcCtD
Fluphenazine—Blood disorder—Epirubicin—uterine cancer	0.00111	0.00461	CcSEcCtD
Fluphenazine—Liver injury—Epirubicin—uterine cancer	0.0011	0.00458	CcSEcCtD
Fluphenazine—HTR2A—renal system—uterine cancer	0.00109	0.00669	CbGeAlD
Fluphenazine—Hypotension—Progesterone—uterine cancer	0.00108	0.00448	CcSEcCtD
Fluphenazine—CALM3—lymph node—uterine cancer	0.00107	0.00658	CbGeAlD
Fluphenazine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00443	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Epirubicin—uterine cancer	0.00105	0.00438	CcSEcCtD
Fluphenazine—HRH1—female reproductive system—uterine cancer	0.00104	0.00642	CbGeAlD
Fluphenazine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00434	CcSEcCtD
Fluphenazine—Dysphagia—Etoposide—uterine cancer	0.00104	0.00431	CcSEcCtD
Fluphenazine—Dyspnoea—Progesterone—uterine cancer	0.00103	0.00427	CcSEcCtD
Fluphenazine—ADRA2A—female reproductive system—uterine cancer	0.00103	0.0063	CbGeAlD
Fluphenazine—Blood disorder—Doxorubicin—uterine cancer	0.00102	0.00427	CcSEcCtD
Fluphenazine—Somnolence—Progesterone—uterine cancer	0.00102	0.00426	CcSEcCtD
Fluphenazine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00424	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—uterine cancer	0.00102	0.00423	CcSEcCtD
Fluphenazine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00422	CcSEcCtD
Fluphenazine—CYP2E1—female reproductive system—uterine cancer	0.001	0.00617	CbGeAlD
Fluphenazine—Decreased appetite—Progesterone—uterine cancer	0.001	0.00416	CcSEcCtD
Fluphenazine—Erythema—Dactinomycin—uterine cancer	0.000997	0.00415	CcSEcCtD
Fluphenazine—CYP2D6—renal system—uterine cancer	0.000991	0.0061	CbGeAlD
Fluphenazine—Dyskinesia—Epirubicin—uterine cancer	0.000984	0.0041	CcSEcCtD
Fluphenazine—Constipation—Progesterone—uterine cancer	0.000984	0.0041	CcSEcCtD
Fluphenazine—Pancytopenia—Etoposide—uterine cancer	0.000983	0.00409	CcSEcCtD
Fluphenazine—ABCB1—myometrium—uterine cancer	0.00098	0.00602	CbGeAlD
Fluphenazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000975	0.00406	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000974	0.00405	CcSEcCtD
Fluphenazine—HRH1—female gonad—uterine cancer	0.00095	0.00584	CbGeAlD
Fluphenazine—HRH1—vagina—uterine cancer	0.000944	0.0058	CbGeAlD
Fluphenazine—ADRA2A—female gonad—uterine cancer	0.000933	0.00574	CbGeAlD
Fluphenazine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00093	0.00387	CcSEcCtD
Fluphenazine—Pneumonia—Etoposide—uterine cancer	0.000929	0.00386	CcSEcCtD
Fluphenazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000927	0.00386	CcSEcCtD
Fluphenazine—ADRA2A—vagina—uterine cancer	0.000927	0.0057	CbGeAlD
Fluphenazine—Hepatocellular injury—Epirubicin—uterine cancer	0.000925	0.00385	CcSEcCtD
Fluphenazine—Urticaria—Progesterone—uterine cancer	0.000914	0.00381	CcSEcCtD
Fluphenazine—Abnormal dreams—Epirubicin—uterine cancer	0.000914	0.00381	CcSEcCtD
Fluphenazine—Dyskinesia—Doxorubicin—uterine cancer	0.000911	0.00379	CcSEcCtD
Fluphenazine—Body temperature increased—Progesterone—uterine cancer	0.00091	0.00379	CcSEcCtD
Fluphenazine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000907	0.00377	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Epirubicin—uterine cancer	0.000898	0.00374	CcSEcCtD
Fluphenazine—Leukopenia—Dactinomycin—uterine cancer	0.000892	0.00371	CcSEcCtD
Fluphenazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000892	0.00371	CcSEcCtD
Fluphenazine—HTR2A—female reproductive system—uterine cancer	0.000872	0.00536	CbGeAlD
Fluphenazine—Agranulocytosis—Etoposide—uterine cancer	0.000861	0.00359	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—uterine cancer	0.000856	0.00356	CcSEcCtD
Fluphenazine—Hypersensitivity—Progesterone—uterine cancer	0.000848	0.00353	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—uterine cancer	0.000846	0.00352	CcSEcCtD
Fluphenazine—CALM2—lymph node—uterine cancer	0.000841	0.00517	CbGeAlD
Fluphenazine—CALM1—lymph node—uterine cancer	0.000837	0.00515	CbGeAlD
Fluphenazine—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000831	0.00346	CcSEcCtD
Fluphenazine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000829	0.00345	CcSEcCtD
Fluphenazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000824	0.00343	CcSEcCtD
Fluphenazine—Pruritus—Progesterone—uterine cancer	0.000814	0.00339	CcSEcCtD
Fluphenazine—CYP2D6—female reproductive system—uterine cancer	0.000794	0.00488	CbGeAlD
Fluphenazine—HTR2A—vagina—uterine cancer	0.000788	0.00485	CbGeAlD
Fluphenazine—ABCB1—epithelium—uterine cancer	0.000769	0.00473	CbGeAlD
Fluphenazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000768	0.0032	CcSEcCtD
Fluphenazine—Photosensitivity—Epirubicin—uterine cancer	0.000765	0.00318	CcSEcCtD
Fluphenazine—ABCB1—uterine cervix—uterine cancer	0.000762	0.00469	CbGeAlD
Fluphenazine—Eczema—Epirubicin—uterine cancer	0.000747	0.00311	CcSEcCtD
Fluphenazine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000738	0.00307	CcSEcCtD
Fluphenazine—Renal failure acute—Epirubicin—uterine cancer	0.000727	0.00303	CcSEcCtD
Fluphenazine—ABCB1—decidua—uterine cancer	0.000726	0.00447	CbGeAlD
Fluphenazine—CYP2D6—female gonad—uterine cancer	0.000723	0.00444	CbGeAlD
Fluphenazine—Headache—Progesterone—uterine cancer	0.000721	0.003	CcSEcCtD
Fluphenazine—ABCB1—renal system—uterine cancer	0.000713	0.00439	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000712	0.00296	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—uterine cancer	0.000708	0.00295	CcSEcCtD
Fluphenazine—Decreased appetite—Dactinomycin—uterine cancer	0.000707	0.00294	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000694	0.00289	CcSEcCtD
Fluphenazine—Muscle spasms—Etoposide—uterine cancer	0.000694	0.00289	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—uterine cancer	0.000691	0.00288	CcSEcCtD
Fluphenazine—ABCB1—endometrium—uterine cancer	0.00069	0.00424	CbGeAlD
Fluphenazine—Lethargy—Epirubicin—uterine cancer	0.000685	0.00285	CcSEcCtD
Fluphenazine—Nausea—Progesterone—uterine cancer	0.000684	0.00285	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—uterine cancer	0.000673	0.0028	CcSEcCtD
Fluphenazine—ABCB1—mammalian vulva—uterine cancer	0.000667	0.0041	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000658	0.00274	CcSEcCtD
Fluphenazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000653	0.00272	CcSEcCtD
Fluphenazine—Leukopenia—Etoposide—uterine cancer	0.000646	0.00269	CcSEcCtD
Fluphenazine—Body temperature increased—Dactinomycin—uterine cancer	0.000643	0.00268	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000642	0.00267	CcSEcCtD
Fluphenazine—Cardiac arrest—Epirubicin—uterine cancer	0.000639	0.00266	CcSEcCtD
Fluphenazine—ABCB1—uterus—uterine cancer	0.000635	0.00391	CbGeAlD
Fluphenazine—Lethargy—Doxorubicin—uterine cancer	0.000634	0.00264	CcSEcCtD
Fluphenazine—Hypertension—Etoposide—uterine cancer	0.000623	0.00259	CcSEcCtD
Fluphenazine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000619	0.00258	CcSEcCtD
Fluphenazine—HRH1—lymph node—uterine cancer	0.000611	0.00375	CbGeAlD
Fluphenazine—ADRA2A—lymph node—uterine cancer	0.0006	0.00369	CbGeAlD
Fluphenazine—Hypersensitivity—Dactinomycin—uterine cancer	0.000599	0.00249	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—uterine cancer	0.000591	0.00246	CcSEcCtD
Fluphenazine—Anaphylactic shock—Etoposide—uterine cancer	0.000589	0.00245	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—uterine cancer	0.00058	0.00242	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—uterine cancer	0.00058	0.00242	CcSEcCtD
Fluphenazine—Tachycardia—Etoposide—uterine cancer	0.000575	0.00239	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—uterine cancer	0.000575	0.00239	CcSEcCtD
Fluphenazine—Skin disorder—Etoposide—uterine cancer	0.000572	0.00238	CcSEcCtD
Fluphenazine—ABCB1—female reproductive system—uterine cancer	0.000571	0.00351	CbGeAlD
Fluphenazine—Pancytopenia—Epirubicin—uterine cancer	0.000551	0.00229	CcSEcCtD
Fluphenazine—Hypotension—Etoposide—uterine cancer	0.00055	0.00229	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000539	0.00225	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—uterine cancer	0.000537	0.00224	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—uterine cancer	0.000537	0.00224	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—uterine cancer	0.000532	0.00221	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00053	0.0022	CcSEcCtD
Fluphenazine—Dyspnoea—Etoposide—uterine cancer	0.000525	0.00218	CcSEcCtD
Fluphenazine—Somnolence—Etoposide—uterine cancer	0.000523	0.00218	CcSEcCtD
Fluphenazine—Pneumonia—Epirubicin—uterine cancer	0.00052	0.00217	CcSEcCtD
Fluphenazine—ABCB1—female gonad—uterine cancer	0.00052	0.0032	CbGeAlD
Fluphenazine—Drowsiness—Epirubicin—uterine cancer	0.000517	0.00215	CcSEcCtD
Fluphenazine—ABCB1—vagina—uterine cancer	0.000517	0.00318	CbGeAlD
Fluphenazine—Decreased appetite—Etoposide—uterine cancer	0.000512	0.00213	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—uterine cancer	0.00051	0.00212	CcSEcCtD
Fluphenazine—Constipation—Etoposide—uterine cancer	0.000503	0.0021	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000499	0.00208	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00049	0.00204	CcSEcCtD
Fluphenazine—Nausea—Dactinomycin—uterine cancer	0.000483	0.00201	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—uterine cancer	0.000483	0.00201	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—uterine cancer	0.000482	0.002	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—uterine cancer	0.000479	0.00199	CcSEcCtD
Fluphenazine—Urticaria—Etoposide—uterine cancer	0.000468	0.00195	CcSEcCtD
Fluphenazine—Body temperature increased—Etoposide—uterine cancer	0.000465	0.00194	CcSEcCtD
Fluphenazine—Oedema peripheral—Epirubicin—uterine cancer	0.000458	0.0019	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—uterine cancer	0.000447	0.00186	CcSEcCtD
Fluphenazine—Hypersensitivity—Etoposide—uterine cancer	0.000434	0.00181	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—uterine cancer	0.000423	0.00176	CcSEcCtD
Fluphenazine—Pruritus—Etoposide—uterine cancer	0.000417	0.00173	CcSEcCtD
Fluphenazine—Erythema—Epirubicin—uterine cancer	0.000404	0.00168	CcSEcCtD
Fluphenazine—Muscle spasms—Epirubicin—uterine cancer	0.000389	0.00162	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—uterine cancer	0.000381	0.00159	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—uterine cancer	0.000374	0.00156	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—uterine cancer	0.000372	0.00155	CcSEcCtD
Fluphenazine—Headache—Etoposide—uterine cancer	0.000369	0.00154	CcSEcCtD
Fluphenazine—Leukopenia—Epirubicin—uterine cancer	0.000362	0.00151	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—uterine cancer	0.00036	0.0015	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—uterine cancer	0.000353	0.00147	CcSEcCtD
Fluphenazine—Nausea—Etoposide—uterine cancer	0.00035	0.00146	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—uterine cancer	0.000349	0.00145	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—uterine cancer	0.000344	0.00143	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—uterine cancer	0.000337	0.0014	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—uterine cancer	0.000335	0.00139	CcSEcCtD
Fluphenazine—ABCB1—lymph node—uterine cancer	0.000334	0.00205	CbGeAlD
Fluphenazine—Anaphylactic shock—Epirubicin—uterine cancer	0.00033	0.00137	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—uterine cancer	0.000323	0.00134	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—uterine cancer	0.000322	0.00134	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—uterine cancer	0.000321	0.00133	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—uterine cancer	0.000312	0.0013	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—uterine cancer	0.000308	0.00128	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000305	0.00127	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—uterine cancer	0.000298	0.00124	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—uterine cancer	0.000297	0.00123	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—uterine cancer	0.000294	0.00122	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—uterine cancer	0.000293	0.00122	CcSEcCtD
Fluphenazine—Decreased appetite—Epirubicin—uterine cancer	0.000287	0.00119	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—uterine cancer	0.000285	0.00119	CcSEcCtD
Fluphenazine—Constipation—Epirubicin—uterine cancer	0.000282	0.00117	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—uterine cancer	0.000272	0.00113	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—uterine cancer	0.000271	0.00113	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—uterine cancer	0.000265	0.0011	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—uterine cancer	0.000262	0.00109	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—uterine cancer	0.000261	0.00109	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—uterine cancer	0.000261	0.00109	CcSEcCtD
Fluphenazine—Hypersensitivity—Epirubicin—uterine cancer	0.000243	0.00101	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—uterine cancer	0.000243	0.00101	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—uterine cancer	0.000241	0.001	CcSEcCtD
Fluphenazine—Pruritus—Epirubicin—uterine cancer	0.000233	0.000972	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—uterine cancer	0.000225	0.000936	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—uterine cancer	0.000216	0.000899	CcSEcCtD
Fluphenazine—Headache—Epirubicin—uterine cancer	0.000207	0.000861	CcSEcCtD
Fluphenazine—Nausea—Epirubicin—uterine cancer	0.000196	0.000816	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—uterine cancer	0.000191	0.000796	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—uterine cancer	0.000181	0.000755	CcSEcCtD
Fluphenazine—CALM1—Immune System—PTEN—uterine cancer	1.51e-05	8.91e-05	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	1.5e-05	8.87e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—AKT1—uterine cancer	1.49e-05	8.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—AKT1—uterine cancer	1.49e-05	8.81e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—EP300—uterine cancer	1.49e-05	8.78e-05	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—AKT1—uterine cancer	1.48e-05	8.75e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CTNNB1—uterine cancer	1.48e-05	8.72e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—VEGFA—uterine cancer	1.47e-05	8.72e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	1.47e-05	8.7e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—NRAS—uterine cancer	1.47e-05	8.7e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—NRAS—uterine cancer	1.47e-05	8.7e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NRAS—uterine cancer	1.46e-05	8.61e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—KRAS—uterine cancer	1.46e-05	8.61e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—VEGFA—uterine cancer	1.45e-05	8.6e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	1.45e-05	8.58e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	1.45e-05	8.56e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—ERBB2—uterine cancer	1.45e-05	8.55e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	1.45e-05	8.55e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	1.44e-05	8.52e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PTEN—uterine cancer	1.44e-05	8.5e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NRAS—uterine cancer	1.44e-05	8.5e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—EP300—uterine cancer	1.44e-05	8.49e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—EP300—uterine cancer	1.44e-05	8.49e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	1.43e-05	8.48e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	1.43e-05	8.47e-05	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—AKT1—uterine cancer	1.43e-05	8.46e-05	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—AKT1—uterine cancer	1.43e-05	8.46e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CTNNB1—uterine cancer	1.43e-05	8.44e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CTNNB1—uterine cancer	1.43e-05	8.44e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—ERBB2—uterine cancer	1.42e-05	8.41e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—ERBB2—uterine cancer	1.42e-05	8.39e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCL2—uterine cancer	1.42e-05	8.37e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PTEN—uterine cancer	1.4e-05	8.3e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PTEN—uterine cancer	1.4e-05	8.26e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PTEN—uterine cancer	1.39e-05	8.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PTEN—uterine cancer	1.39e-05	8.22e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—NRAS—uterine cancer	1.39e-05	8.21e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—EP300—uterine cancer	1.37e-05	8.11e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CXCL8—uterine cancer	1.37e-05	8.1e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCL2—uterine cancer	1.37e-05	8.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCL2—uterine cancer	1.37e-05	8.1e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—AKT1—uterine cancer	1.37e-05	8.1e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—AKT1—uterine cancer	1.36e-05	8.06e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—HRAS—uterine cancer	1.36e-05	8.05e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CXCL8—uterine cancer	1.35e-05	7.97e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CXCL8—uterine cancer	1.35e-05	7.96e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NRAS—uterine cancer	1.34e-05	7.95e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NRAS—uterine cancer	1.34e-05	7.95e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—HRAS—uterine cancer	1.34e-05	7.92e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EP300—uterine cancer	1.34e-05	7.92e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	1.34e-05	7.92e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—PIK3CA—uterine cancer	1.34e-05	7.91e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—HRAS—uterine cancer	1.34e-05	7.91e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EP300—uterine cancer	1.33e-05	7.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EP300—uterine cancer	1.33e-05	7.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EP300—uterine cancer	1.33e-05	7.84e-05	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	1.32e-05	7.83e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTEN—uterine cancer	1.32e-05	7.8e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	1.32e-05	7.79e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	1.32e-05	7.79e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	1.31e-05	7.77e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—MTHFR—uterine cancer	1.31e-05	7.74e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—KRAS—uterine cancer	1.31e-05	7.74e-05	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	1.3e-05	7.7e-05	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	1.3e-05	7.69e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—uterine cancer	1.29e-05	7.65e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	1.29e-05	7.65e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NRAS—uterine cancer	1.28e-05	7.58e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—uterine cancer	1.27e-05	7.5e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—KRAS—uterine cancer	1.27e-05	7.49e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—KRAS—uterine cancer	1.27e-05	7.49e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	1.26e-05	7.48e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—uterine cancer	1.26e-05	7.46e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—EP300—uterine cancer	1.26e-05	7.44e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KRAS—uterine cancer	1.25e-05	7.41e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NRAS—uterine cancer	1.25e-05	7.41e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NRAS—uterine cancer	1.25e-05	7.37e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	1.24e-05	7.36e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	1.24e-05	7.34e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NRAS—uterine cancer	1.24e-05	7.34e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NRAS—uterine cancer	1.24e-05	7.34e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—HRAS—uterine cancer	1.24e-05	7.32e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KRAS—uterine cancer	1.24e-05	7.31e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PTEN—uterine cancer	1.23e-05	7.29e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	1.23e-05	7.26e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	1.22e-05	7.21e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PTEN—uterine cancer	1.21e-05	7.17e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTEN—uterine cancer	1.21e-05	7.16e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PTEN—uterine cancer	1.21e-05	7.16e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTEN—uterine cancer	1.2e-05	7.12e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—AKT1—uterine cancer	1.2e-05	7.11e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—PIK3CA—uterine cancer	1.2e-05	7.11e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	1.2e-05	7.09e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KRAS—uterine cancer	1.2e-05	7.07e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	1.19e-05	7.01e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	1.18e-05	7e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—AKT1—uterine cancer	1.18e-05	6.98e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ERBB2—uterine cancer	1.18e-05	6.98e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EP300—uterine cancer	1.18e-05	6.95e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTEN—uterine cancer	1.16e-05	6.89e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTEN—uterine cancer	1.16e-05	6.89e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—uterine cancer	1.16e-05	6.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PIK3CA—uterine cancer	1.16e-05	6.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—uterine cancer	1.16e-05	6.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—uterine cancer	1.16e-05	6.84e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EP300—uterine cancer	1.16e-05	6.84e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—EP300—uterine cancer	1.16e-05	6.83e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EP300—uterine cancer	1.15e-05	6.82e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.15e-05	6.82e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—uterine cancer	1.15e-05	6.81e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—EP300—uterine cancer	1.15e-05	6.79e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ERBB2—uterine cancer	1.14e-05	6.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ERBB2—uterine cancer	1.14e-05	6.75e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—uterine cancer	1.14e-05	6.72e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	1.13e-05	6.69e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL8—uterine cancer	1.12e-05	6.62e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—uterine cancer	1.11e-05	6.59e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—uterine cancer	1.11e-05	6.58e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—uterine cancer	1.11e-05	6.58e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—EP300—uterine cancer	1.11e-05	6.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—EP300—uterine cancer	1.11e-05	6.57e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—uterine cancer	1.1e-05	6.53e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	1.1e-05	6.52e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—uterine cancer	1.1e-05	6.5e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—uterine cancer	1.1e-05	6.5e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—uterine cancer	1.1e-05	6.5e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	1.1e-05	6.48e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1B—uterine cancer	1.09e-05	6.46e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—uterine cancer	1.09e-05	6.46e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—uterine cancer	1.09e-05	6.46e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL8—uterine cancer	1.08e-05	6.4e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL8—uterine cancer	1.08e-05	6.4e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—uterine cancer	1.08e-05	6.4e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—uterine cancer	1.08e-05	6.38e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—uterine cancer	1.08e-05	6.37e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	1.08e-05	6.36e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—uterine cancer	1.08e-05	6.36e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—uterine cancer	1.08e-05	6.36e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—uterine cancer	1.07e-05	6.34e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—uterine cancer	1.07e-05	6.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—uterine cancer	1.07e-05	6.31e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—uterine cancer	1.07e-05	6.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—uterine cancer	1.06e-05	6.28e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—uterine cancer	1.06e-05	6.28e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1B—uterine cancer	1.06e-05	6.25e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1B—uterine cancer	1.06e-05	6.25e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EP300—uterine cancer	1.05e-05	6.22e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—uterine cancer	1.05e-05	6.22e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CTNNB1—uterine cancer	1.03e-05	6.11e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—uterine cancer	1.02e-05	6.01e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—uterine cancer	1.01e-05	6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTEN—uterine cancer	1.01e-05	5.95e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CTNNB1—uterine cancer	9.99e-06	5.91e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CTNNB1—uterine cancer	9.99e-06	5.91e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	9.97e-06	5.89e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	9.9e-06	5.86e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	9.85e-06	5.83e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	9.84e-06	5.82e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—uterine cancer	9.83e-06	5.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—uterine cancer	9.83e-06	5.81e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—uterine cancer	9.82e-06	5.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—uterine cancer	9.81e-06	5.8e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—uterine cancer	9.81e-06	5.8e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTEN—uterine cancer	9.74e-06	5.76e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTEN—uterine cancer	9.74e-06	5.76e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EP300—uterine cancer	9.6e-06	5.68e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—uterine cancer	9.58e-06	5.67e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—uterine cancer	9.53e-06	5.64e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—uterine cancer	9.5e-06	5.62e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—uterine cancer	9.5e-06	5.62e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—uterine cancer	9.46e-06	5.6e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—uterine cancer	9.41e-06	5.56e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—uterine cancer	9.38e-06	5.55e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—uterine cancer	9.31e-06	5.51e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—uterine cancer	9.31e-06	5.5e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—uterine cancer	9.29e-06	5.49e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EP300—uterine cancer	9.29e-06	5.49e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EP300—uterine cancer	9.29e-06	5.49e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—uterine cancer	9.28e-06	5.49e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—uterine cancer	9.16e-06	5.42e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTEN—uterine cancer	9.12e-06	5.4e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—uterine cancer	9.12e-06	5.39e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—uterine cancer	9.09e-06	5.38e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—uterine cancer	9.08e-06	5.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—uterine cancer	9.08e-06	5.37e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—uterine cancer	8.98e-06	5.31e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—uterine cancer	8.97e-06	5.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—uterine cancer	8.8e-06	5.2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—uterine cancer	8.8e-06	5.2e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—EP300—uterine cancer	8.7e-06	5.15e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	8.7e-06	5.14e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—uterine cancer	8.69e-06	5.14e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—uterine cancer	8.69e-06	5.14e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—uterine cancer	8.68e-06	5.13e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—uterine cancer	8.68e-06	5.13e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTEN—uterine cancer	8.6e-06	5.08e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	8.56e-06	5.06e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—uterine cancer	8.55e-06	5.05e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	8.54e-06	5.05e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—uterine cancer	8.49e-06	5.02e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	8.47e-06	5.01e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—uterine cancer	8.41e-06	4.97e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—uterine cancer	8.29e-06	4.9e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—uterine cancer	8.28e-06	4.89e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—uterine cancer	8.26e-06	4.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—uterine cancer	8.22e-06	4.86e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—uterine cancer	8.22e-06	4.86e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—EP300—uterine cancer	8.2e-06	4.85e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—uterine cancer	8.09e-06	4.78e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—uterine cancer	8.05e-06	4.76e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—uterine cancer	8.04e-06	4.76e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—uterine cancer	8.01e-06	4.74e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—uterine cancer	8.01e-06	4.74e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—uterine cancer	7.92e-06	4.68e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—uterine cancer	7.9e-06	4.67e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	7.78e-06	4.6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—uterine cancer	7.73e-06	4.57e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—uterine cancer	7.6e-06	4.5e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—uterine cancer	7.53e-06	4.45e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—uterine cancer	7.48e-06	4.42e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—uterine cancer	7.48e-06	4.42e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTEN—uterine cancer	7.28e-06	4.31e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	7.2e-06	4.26e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—uterine cancer	7.1e-06	4.2e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—uterine cancer	7.1e-06	4.2e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—uterine cancer	6.99e-06	4.13e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—uterine cancer	6.98e-06	4.13e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—uterine cancer	6.97e-06	4.12e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—EP300—uterine cancer	6.95e-06	4.11e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—uterine cancer	6.94e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—uterine cancer	6.87e-06	4.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—uterine cancer	6.87e-06	4.06e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—uterine cancer	6.87e-06	4.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—uterine cancer	6.71e-06	3.97e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—uterine cancer	6.71e-06	3.97e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—uterine cancer	6.65e-06	3.93e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—uterine cancer	6.65e-06	3.93e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—uterine cancer	6.57e-06	3.89e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—uterine cancer	6.44e-06	3.81e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	6.36e-06	3.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—uterine cancer	6.36e-06	3.76e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—uterine cancer	6.36e-06	3.76e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—uterine cancer	6.07e-06	3.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—uterine cancer	5.8e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—uterine cancer	5.61e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—uterine cancer	5.61e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—uterine cancer	5.26e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—uterine cancer	5.14e-06	3.04e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—uterine cancer	4.96e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—uterine cancer	4.2e-06	2.48e-05	CbGpPWpGaD
